G
Gergana Zlateva
Researcher at Pfizer
Publications - 73
Citations - 3514
Gergana Zlateva is an academic researcher from Pfizer. The author has contributed to research in topics: Fibromyalgia & Pregabalin. The author has an hindex of 26, co-authored 73 publications receiving 3147 citations.
Papers
More filters
Journal ArticleDOI
Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis
Usha Chakravarthy,Tien Yin Wong,Tien Yin Wong,Astrid E. Fletcher,Elisabeth Piault,Christopher M. Evans,Gergana Zlateva,Ronald Buggage,Andreas M. Pleil,Paul Mitchell +9 more
TL;DR: Increasing age, current cigarette smoking, previous cataract surgery, and a family history of AMD showed strong and consistent associations with late AMD.
Journal ArticleDOI
The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis.
Tien Wong,Usha Chakravarthy,Ronald Klein,Paul Mitchell,Gergana Zlateva,Ronald Buggage,Kyle Fahrbach,Corey Probst,Isabella Sledge +8 more
TL;DR: A doubling of the visual angle of presenting VA may be expected to occur in the year after initial presentation in eyes with untreated neovascular AMD, and the diversity of reporting formats, paucity of long-term natural history data, and heterogeneity among the reported clinical studies impose limits to the clear understanding ofLong-term prognosis for visual function in neov vascular AMD.
Journal ArticleDOI
Minimal Clinically Important Difference in the Fibromyalgia Impact Questionnaire
TL;DR: Analysis of analyses of the Fibromyalgia Impact Questionnaire indicates that a 14% change in the FIQ total score is clinically relevant, and results of these analyses should enhance the clinical utility of the FIZ in research and practice.
Journal ArticleDOI
Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study.
Gisèle Soubrane,Alan F. Cruess,Andrew J. Lotery,Daniel Pauleikhoff,Jordi Monés,Xiao Xu,Gergana Zlateva,Ronald Buggage,John Conlon,Thomas F. Goss +9 more
TL;DR: In this paper, a cross-sectional study of 401 patients with bilateral neovascular age-related macular degeneration (NV-AMD) and 471 elderly control subjects without AMD was conducted in 5 countries.
Burden and Health Care Resource Utilization in Neovascular Age-Related Macular Degeneration
Gisèle Soubrane,Alan F. Cruess,Andrew J. Lotery,Daniel Pauleikhoff,Jordi Monés,Xiao Xu,Gergana Zlateva,Ronald Buggage,John Conlon,Thomas F. Goss +9 more
TL;DR: The evidence of extensive decline in quality of life and increased need of daily living assistance for patients with NV-AMD compared with a control population substantiates the need for new treatments that prevent vision loss and progression to blindness.